Abiraterone Acetate in Combination with Prednisone for the Treatment of Patients with Metastatic Castration-Resistant Prostate Cancer: U.S. Food and Drug Administration Drug Approval Summary

Paul G. Kluetz, Richard Pazdur, V. Ellen Maher et al.|Clinical Cancer Research|2013

Cited by 62